维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="OUARET D"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis显示文摘	Larsen AK Ouaret D El Ouadrani K		0，，01：	1
	2	Targeting EGFR and VEGF (R)pathway cross -talk in tumor survival and angiogenesis 显示文摘	Larsen AK Ouaret D E10uadrani K	2011	Pharmacol Ther2011，131，1：	1
	3	Targeting EGFR and VEGF (R) pathway cross-talk in tumor survival and angiogenesis 显示文摘	Larsen AK Ouaret D E10uadrani K	2011	Pharmacol Ther2011，131，1：	1
	4	Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis显示文摘	Larsen AK1 Ouaret D El Ouadrani K	2011	Pharmacol Ther2011，131，1：	1
	5	Targeting EGFR and VEGF(R)pathway cross-talk in tumor survival and angiogenesis显示文摘	Larsen AK Ouaret D El Ouadrani K	2011	Pharmacol Ther2011，131，1：	1
	6	Targeting EGFR and VEGF(R)pathway cross-talk in tumor survival and angiogenesis显示文摘	Larsen AK Ouaret D El Ouadrani K		0，，01：	1
	7	Targeting EG- FR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis显示文摘	Larsen AK Ouaret D E10uadrani K	2011	Pharmacol Ther2011，131，1：	1
	8	EGFR-andVEGF(R)-targeted small molecules show synergisticactivity in colorectal cancer models refractory to combinationsof monoclonal antibodies显示文摘	Poindessous V Ouaret D Battistella A	2011	Clin Cancer Res2011，17，20：	1
	9	Targeting EGFR and VEGF (R) pathway cross-talk in tumor survival and angiogenesis显示文摘	Larsen AK Ouaret D El Ouadrani K		0，，：	1
	10	Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis 显示文摘	Larsen AK Ouaret D E10uadrani K	2011	Pharmacol Ther2011，131，1：	1
	11	Targeting EGFR and vegf(r) pathway cross-talk in tumor survival and angiogenesis显示文摘	LARSEN A K OUARET D EI-OUADRANI K	2011	Pharmacol Ther2011，131，1：	1
	12	Protein kinase C 13 inhibition by enzastaurin leads to mitotic misscgregation and preferential cytotoxicity toward colorectal cancer cells with chromosomal instability (CIN)显示文摘	Ouaret D Larsen AK	2014	Cell Cycle2014，13，17：	1
	13	EGFR- and VEGF (R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combina- tions of monoelonal antibodies 显示文摘	Poindessous V Ouaret D E1 Ouadrani K	2011	Clin Cancer Res2011，17，20：	1
	14	Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis显示文摘	Larsen AK Ouaret D ElOuadrani K		0，，01：	1
	15	EGFR- and VEGF (R)-targeted small molecules show synergistic ac- tivity in colorectal cancer models refractory to combina- tions of monoclonal antibodies 显示文摘	Poindessous V Ouaret D E1 OK	2011	Clin Cancer Res2011，17，20：	1
	16	Rapidly derived colorectal cancer cultures recapitulate parental cancer characteristics and enable personalised therapeutic assays 显示文摘	ASHLEY N JONES M OUARET D	2014	J Pathol2014，1，1：	1
	17	Protein kinase C beta inhibition by enzastaurin leads to mitotic missegregation and preferential cytotoxicity toward colorectal cancer cells with chromosomal instability (CIN) 显示文摘	Ouaret D Larsen AK	2014	Cell Cycle2014，13，17：	1
	18	EGFR-and VEGF ( R) 'targeted small molecules show syn-ergistic activity in colorectal cancer models refracto-ry to combinations of monoclonal antibodies 显示文摘	Poindessous V Ouaret D El OK	2011	Clin Cancer Res2011，17，20：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费